We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-15.18%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$506M
AUM Growth
-$198M
Cap. Flow
-$88.8M
Cap. Flow %
-17.55%
Top 10 Hldgs %
91.48%
Holding
42
New
10
Increased
4
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$17.6M
2
WGS icon
GeneDx Holdings
WGS
+$13.3M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.52M
4
IBRX icon
ImmunityBio
IBRX
+$2.45M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$802K

Top Sells

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$36M
2
PFE icon
Pfizer
PFE
+$24.6M
3
QDEL icon
QuidelOrtho
QDEL
+$15.6M
4
OPK icon
Opko Health
OPK
+$11.4M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.96M

Sector Composition

Rank Sector Weight
1 Healthcare 94.94%
2 Energy 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$244M 48.33%
2,061,402
-14,000
-0.7% -$1.75M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$79.7M 15.76%
708,631
-146,437
-17% -$15.6M
OPK icon
3
Opko Health
OPK
$1.25B
$30.9M 6.11%
8,985,756
-3,233,317
-26% -$11.4M
BCRX icon
4
BioCryst Pharmaceuticals
BCRX
$2.48B
$28M 5.53%
1,720,733
+50,000
+3% +$802K
AGEN
5
Agenus
AGEN
$275M
$21.4M 4.24%
443,577
-20,380
-4% -$1.1M
ARKK icon
6
ARK Innovation ETF
ARKK
$5.74B
$16.6M 3.28%
+250,000
New +$17.6M
WGS icon
7
GeneDx Holdings
WGS
$1.84B
$12.1M 2.39%
+119,540
New +$13.3M
PACB icon
8
Pacific Biosciences
PACB
$432M
$11.2M 2.21%
1,225,395
-195,257
-14% -$2.25M
DMTK
9
DELISTED
DermTech, Inc. Common Stock
DMTK
$9.59M 1.9%
652,907
+50,000
+8% +$669K
FORA
10
DELISTED
Forian
FORA
$8.78M 1.74%
1,262,040
+42,379
+3% +$313K
CFRX
11
DELISTED
ContraFect Corporation
CFRX
$7.13M 1.41%
24,428
+23
+0.1% +$5.59K
ATRS
12
DELISTED
Antares Pharma, Inc.
ATRS
$7.05M 1.39%
1,720,000
– –
ACAD icon
13
Acadia Pharmaceuticals
ACAD
$4.45B
$4.52M 0.89%
+186,789
New +$4.52M
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
$3.93M 0.78%
273,186
-89,569
-25% -$2.55M
CDAK
15
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$3.16M 0.63%
504,602
-154,589
-23% -$970K
IMMP
16
Immutep
IMMP
$57M
$2.67M 0.53%
976,156
– –
IBRX icon
17
ImmunityBio
IBRX
$7.3B
$2.24M 0.44%
+400,013
New +$2.45M
AWH
18
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$2.2M 0.44%
141,123
-228,683
-62% -$3.96M
LABU icon
19
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$538M
$1.77M 0.35%
+50,000
New +$18.8M
CNC icon
20
PUT
Centene
CNC
$31.6B
$1.49M 0.29%
300,000
-116,300
-28% -$9.54M
PFE icon
21
PUT
Pfizer
PFE
$144B
$1.26M 0.25%
550,000
-850,000
-61% -$44.1M
BCRX icon
22
PUT
BioCryst Pharmaceuticals
BCRX
$2.48B
$1.26M 0.25%
550,000
-150,000
-21% -$2.41M
ACAD icon
23
PUT
Acadia Pharmaceuticals
ACAD
$4.45B
$1.06M 0.21%
+459,300
New +$11.1M
DMTK
24
PUT
DELISTED
DermTech, Inc. Common Stock
DMTK
$921K 0.18%
193,800
-56,200
-22% -$752K
VTNR
25
DELISTED
Vertex Energy, Inc
VTNR
$547K 0.11%
+55,000
New +$336K
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Oracle Investment Management held 42 positions worth $506M, down 28% from $704M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Oracle Investment Management withdrew a net $88.8M in Q1 2022, closing 10 positions and reducing 14 holdings. Its most notable exit was Vir Biotechnology, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 97% a quarter earlier, followed by Energy.

Against the trend, Oracle Investment Management opened a new position in ARK Innovation ETF worth $16.6M.

  • Oracle Investment Management's largest Q1 2022 buy was ARK Innovation ETF: 250,000 shares worth $16.6M.
  • Oracle Investment Management added most to BioCryst Pharmaceuticals in Q1 2022, an estimated $802K increase.
  • Oracle Investment Management's biggest Q1 2022 reduction was QuidelOrtho, cutting an estimated $15.6M.
  • Oracle Investment Management fully exited Vir Biotechnology in Q1 2022, selling an estimated $36M.
  • Oracle Investment Management's ten largest holdings make up 91% of its $506M portfolio in Q1 2022.
  • Oracle Investment Management opened 10 new positions and closed 10 in Q1 2022.
  • Oracle Investment Management's portfolio value fell 28% quarter-over-quarter to $506M.

Based on Oracle Investment Management's 13F filing for Q1 2022, filed 16 May 2022.